Tools

Search

Explore

Videos Channels Figures

Atmrix

About

Tools

Search

Explore

Videos Channels Figures

Atmrix

About

EI

Elizabeth Iorns

09/14/17

@ Y Combinator

Successful biotech funds often incubate ideas internally before spinning them out as independent companies, which has proven effective in the industry.

Video

YC

Elizabeth Iorns on Biotech Companies in YC

@ Y Combinator

Elizabeth Iorns on Biotech Companies in YC

09/14/17

Related Takeaways

EI

Elizabeth Iorns

09/14/17

@ Y Combinator

Biotech fundraising is increasingly resembling traditional paths seen in software, with many funds showing interest in innovative science companies.

EI

Elizabeth Iorns

09/14/17

@ Y Combinator

There is a growing interest from early-stage technology investors in funding biotech companies, with many successfully raising significant seed funding.

EI

Elizabeth Iorns

09/14/17

@ Y Combinator

Biotech companies often use their time in Y Combinator to conduct critical path experiments and work with external companies for proof of concept studies, which can advance their regulatory filing status.

EI

Elizabeth Iorns

09/14/17

@ Y Combinator

There is a growing trend of former students starting biotech companies, which encourages others to explore similar entrepreneurial paths.

PB

Paul Buchheit

03/07/18

@ Y Combinator

Investing in things that aren't software is okay if you believe in the founder's expertise; there are many great opportunities in biotech that could lead to significant exits.

EI

Elizabeth Iorns

09/14/17

@ Y Combinator

There's a significant gap in funding for early-stage biotech discoveries, leading many companies to apply to Y Combinator when they have initial data suggesting a promising approach to curing diseases.

YC

Y Combinator Cast

09/20/18

@ Y Combinator

Companies with particularly novel ideas can consider press outreach even before launching a product, especially in fields like biotechnology.

EI

Elizabeth Iorns

09/14/17

@ Y Combinator

Biotech companies benefit from Y Combinator through access to capital, fundraising expertise, and interaction with diverse sectors, which can lead to unexpected advantages.

EI

Elizabeth Iorns

10/03/18

@ Y Combinator

Biotech founders often make the mistake of not conducting the essential experiments needed to validate their ideas, fearing that failure could jeopardize their startups.